Exosens Stock Hits a Record High of €73.5 at Opening
EXOSENS stock shows a significant increase this Wednesday, March 18, trading at €73.5 during the session, up 2.23% from the last close at €71.9. The stock simultaneously crosses two significant thresholds: a new all-time high surpassing the previous record of €72.8, and a monthly change exceeding 20%, two signals that cumulatively put the stock in the spotlight. These movements occur in a well-oriented Parisian market context, with the CAC 40 up 0.87% during the session.
New Absolute Record for EXOSENS
This morning, EXOSENS sets a new absolute record at €73.5, thus surpassing the previous historical high of €72.8. This progression is part of a particularly marked monthly dynamic, with a gain exceeding 20% over the last thirty rolling days, a threshold that anomaly detection algorithms consider a statistical anomaly compared to the usual behavior of the stock. On broader horizons, the performance remains remarkable: the stock shows a gain of 8.41% over seven days, 23.95% over three months, and 115.8% over one year, reflecting a deep revaluation of the stock from last year's levels. However, the general context remains marked by measured tension, with the VIX at 27.19, a level indicating still high implied volatility in the equity markets.
Technical Analysis Perspective
From a technical analysis standpoint, the stock is trading well above its two reference moving averages: the MM50 stands at €58.73 and the MM200 at €47.04, levels now respectively €15 and €26 away from the current price. This positioning reflects a well-established structural upward trend, maintained over several months. The RSI is at 75, indicating a technical overbought territory, which shows that the buying dynamics have been particularly strong in the recent period. Moreover, the stock crosses the upper Bollinger band, set at €72.20, confirming that the ongoing movement is outside the statistically usual amplitudes for the stock. The next milestone to watch on the company's financial calendar is the publication of the first quarter 2026 results, expected on April 27.
